Agmatine: an endogenous clonidine-displacing substance in the brain
Version 2 2024-06-03, 13:01Version 2 2024-06-03, 13:01
Version 1 2017-07-26, 12:50Version 1 2017-07-26, 12:50
journal contribution
posted on 2024-06-03, 13:01authored byG Li, S Regunathan, Colin BarrowColin Barrow, J Eshraghi, R Cooper, DJ Reis
Clonidine, an antihypertensive drug, binds to alpha 2-adrenergic and imidazoline receptors. The endogenous ligand for imidazoline receptors may be a clonidine-displacing substance, a small molecule isolated from bovine brain. This clonidine-displacing substance was purified and determined by mass spectroscopy to be agmatine (decarboxylated arginine), heretofore not detected in brain. Agmatine binds to alpha 2-adrenergic and imidazoline receptors and stimulates release of catecholamines from adrenal chromaffin cells. Its biosynthetic enzyme, arginine decarboxylase, is present in brain. Agmatine, locally synthesized, is an endogenous agonist at imidazoline receptors, a noncatecholamine ligand at alpha 2-adrenergic receptors and may act as a neurotransmitter.
History
Journal
Science
Volume
263
Pagination
966-969
Location
Washington, D.C.
ISSN
0036-8075
eISSN
1095-9203
Language
eng
Publication classification
C1.1 Refereed article in a scholarly journal
Copyright notice
1994, American Association for the Advancement of Science
Issue
5149
Publisher
American Association for the Advancement of Science